คณะแพทยศาสตร์โรงพยาบาลรามาธิบดี มหาวิทยาลัยมหิดล
ภาควิชาอายุรศาสตร์
☰

    ปรัชญา: ความสำเร็จที่แท้จริงอยู่ที่การนำความรู้ไปประยุกต์ใช้เพื่อประโยชน์สุขแก่มวลมนุษยชาติ

You are here

Home

ผลงานวิจัย หน่วยโรคทางเดินอาหาร

Division of Gastroenterology & Tropical Medicine (หน่วยโรคทางเดินอาหาร)

2021

  1. The Perils and Pitfalls of Esophageal Dysmotility in Idiopathic Pulmonary Fibrosis. Cheah R, Chirnaksorn S, Abdelrahim AH, Horgan L, Capstick T, Casey J, Peckham D, Boland A, Sutherland TJT, Beirne P, Lee AS, DeVault KR, Houghton LA. Am J Gastroenterol. 2021 Jun 1;116(6):1189-1200. doi: 10.14309/ajg.0000000000001202. PMID: 34074825

  2. Cost-Utility Analysis of Vasoconstrictors Plus Albumin in the Treatment of Thai Patients with Type 1 Hepatorenal Syndrome. Sangroongruangsri S, Kittrongsiri K, Charatcharoenwitthaya P, Sobhonslidsuk A, Chaikledkaew U. Clinicoecon Outcomes Res. 2021 Jul 29;13:703-715. doi: 10.2147/CEOR.S317390. eCollection 2021. PMID: 34349534 Free PMC article.

  3. Prevalence and predicting factors of metabolic-associated fatty liver disease diagnosed by transient elastography with controlled attenuation parameters in HIV-positive people. Jongraksak T, Sobhonslidsuk A, Jatchavala J, Warodomwichit D, Kaewduang P, Sungkanuparph S. Int J STD AIDS. 2021 Mar;32(3):266-275. doi: 10.1177/0956462420960997. Epub 2020 Dec 18. PMID: 33334267

  4. Diffuse gallbladder wall thickening in autoimmune hepatitis: an unusual presentation. Rattananukrom C, Angkathunyakul N, Sobhonslidsuk A. BMJ Case Rep. 2021 May 31;14(5):e241325. doi: 10.1136/bcr-2020-241325. PMID: 34059540

  5. Role of highly sensitive nucleic acid amplification testing for plasma cytomegalovirus DNA load in diagnosis of cytomegalovirus gastrointestinal disease among kidney transplant recipients. Taksinwarajarn T, Sobhonslidsuk A, Kantachuvesiri S, Thongprayoon C, Cheungpasitporn W, Bruminhent J; Ramathibodi Transplant Infectious Diseases (RTID) group. Transpl Infect Dis. 2021 May 13:e13635. doi: 10.1111/tid.13635. Online ahead of print.

2020

  1. Imidacloprid poisoning case series: potential for liver injury. Sriapha C, Trakulsrichai S, Intaraprasong P, Wongvisawakorn S, Tongpoo A, Schimmel J, Wananukul W. Clin Toxicol (Phila). 2020 Feb;58(2):136-138. doi: 10.1080/15563650.2019.161609 Epub 2019 May 16. PMID: 31092066
  2. Outcomes of delayed endoscopic retrograde cholangiopancreatography in patients with acute biliary pancreatitis with cholangitis. Muangkaew P, Kamalaporn P, Mingphruedhi S, Rungsakulkij N, Suragul W, Vassanasiri W, Tangtawee P. Asian J Surg. 2020 Sep;43(9):913-918. doi: 10.1016/j.asjsur.2019.11.011. Epub 2020 Jan 6. PMID: 31917033 Free article.
  3. Real-world effectiveness and safety of sofosbuvir and nonstructural protein 5A inhibitors for chronic hepatitis C genotype 1, 2, 3, 4, or 6: a multicentre cohort study. Charatcharoenwitthaya P, Wongpaitoon V, Komolmit P, Sukeepaisarnjaroen W, Tangkijvanich P, Piratvisuth T, Sanpajit T, Sutthivana C, Bunchorntavakul C, Sobhonslidsuk A, Chonprasertsuk S, Siripipattanamongkol C, Sethasine S, Tanwandee T; THASL Collaborating Group for the Study of the Use of Direct-acting Antivirals for Chronic Hepatitis C. BMC Gastroenterol. 2020 Mar 5;20(1):47. doi: 10.1186/s12876-020-01196-0. PMID: 32138687 Free PMC article.
  4. Evaluation of aspartate aminotransferase to platelet ratio index and fibrosis 4 scores for hepatic fibrosis assessment compared with transient elastography in chronic hepatitis C patients. Sripongpun P, Tangkijvanich P, Chotiyaputta W, Charatcharoenwitthaya P, Chaiteerakij R, Treeprasertsuk S, Bunchorntavakul C, Sobhonslidsuk A, Leerapun A, Khemnark S, Poovorawan K, Siramolpiwat S, Chirapongsathorn S, Pan-Ngum W, Soonthornworasiri N, Sukeepaisarnjaroen W; THASL study group. JGH Open. 2019 Jun 26;4(1):69-7 doi: 10.1002/jgh3.12219. eCollection 2020 Feb. PMID: 32055700 Free PMC article.
  5. Cost-Utility Analysis of Direct-Acting Antivirals for Treatment of Chronic Hepatitis C Genotype 1 and 6 in Vietnam. Due OT, Thakkinstian A, Thavorncharoensap M, Sobhonslidsuk A, Wu O, Phuong NK, Chaikledkaew U. Value Health. 2020 Sep;23(9):1180-1190. doi: 10.1016/j.jval.2020.03.018. Epub 2020 Jul 20. PMID: 32940236 Free PMC article.
  6. Prevalence and predicting factors of metabolic-associated fatty liver disease diagnosed by transient elastography with controlled attenuation parameters in HIV-positive people. Jongraksak T, Sobhonslidsuk A, Jatchavala J, Warodomwichit D, Kaewduang P, Sungkanuparph S. Int J STD AIDS. 2021 Mar;32(3):266-275. doi: 10.1177/0956462420960997. Epub 2020 Dec 18.

 

2019

  1. Abdominal Obesity as a Predictive Factor of Nonalcoholic Fatty Liver Disease Assessed by Ultrasonography and Transient Elastography in Polycystic Ovary Syndrome and Healthy Women.Tantanavipas S, Vallibhakara O, Sobhonslidsuk A, Phongkitkarun S, Vallibhakara SA, Promson K, Sophonsritsuk A.Biomed Res Int. 2019 Aug 4;2019:9047324. doi: 10.1155/2019/9047324. eCollection 2019.
  2. Alcohol relapse and its predictors after liver transplantation for alcoholic liver disease: a systematic review and meta-analysis.Chuncharunee L, Yamashiki N, Thakkinstian A, Sobhonslidsuk A.BMC Gastroenterol. 2019 Aug 22;19(1):150. doi: 10.1186/s12876-019-1050-9.
  3. Imidacloprid poisoning case series: potential for liver injury.Sriapha C, Trakulsrichai S, Intaraprasong P, Wongvisawakorn S, Tongpoo A, Schimmel J, Wananukul W.Clin Toxicol (Phila). 2019 May 16:1- doi: 10.1080/15563650.2019.1616091. [Epub ahead of print]
  4. Sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial.Wei L, Lim SG, Xie Q, Văn KN, Piratvisuth T, Huang Y, Wu S, Xu M, Tang H, Cheng J, Le Manh H, Gao Y, Mou Z, Sobhonslidsuk A, Dou X, Thongsawat S, Nan Y, Tan CK, Ning Q, Tee HP, Mao Y, Stamm LM, Lu S, Dvory-Sobol H, Mo H, Brainard DM, Yang YF, Dao L, Wang GQ, Tanwandee T, Hu P, Tangkijvanich P, Zhang L, Gao ZL, Lin F, Le TTP, Shang J, Gong G, Li J, Su M, Duan Z, Mohamed R, Hou JL, Jia J.Lancet Gastroenterol Hepatol. 2019 Feb;4(2):127-13 doi: 10.1016/S2468-1253(18)30343-1. Epub 2018 Dec 14.
  5. Thailand Dyspepsia Guidelines: 2018.Pittayanon R, Leelakusolvong S, Vilaichone RK, Rojborwonwitaya J, Treeprasertsuk S, Mairiang P, Chirnaksorn S, Chitapanarux T, Kaosombatwattana U, Sottisuporn J, Sansak I, Phisalprapa P, Bunchorntavakul C, Chuenrattanakul S, Chakkaphak S, Boonsirichan R, Wiwattanachang O, Maneerattanaporn M, Piyanirun W, Mahachai V.J Neurogastroenterol Motil. 2019 Jan 31;25(1):15-26. doi: 10.5056/jnm18081

 

2018

  1. Sofosbuvir-velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial.Wei L, Lim SG, Xie Q, Văn KN, Piratvisuth T, Huang Y, Wu S, Xu M, Tang H, Cheng J, Le Manh H, Gao Y, Mou Z, Sobhonslidsuk A, Dou X, Thongsawat S, Nan Y, Tan CK, Ning Q, Tee HP, Mao Y, Stamm LM, Lu S, Dvory-Sobol H, Mo H, Brainard DM, Yang YF, Dao L, Wang GQ, Tanwandee T, Hu P, Tangkijvanich P, Zhang L, Gao ZL, Lin F, Le TTP, Shang J, Gong G, Li J, Su M, Duan Z, Mohamed R, Hou JL, Jia J.Lancet Gastroenterol Hepatol. 2019 Feb;4(2):127-134. doi: 10.1016/S2468-1253(18)30343- Epub 2018 Dec 14.
  2. Clinical Outcomes after Liver Transplantation for Hepatorenal Syndrome: A Systematic Review and Meta-Analysis.Utako P, Emyoo T, Anothaisintawee T, Yamashiki N, Thakkinstian A, Sobhonslidsuk A.Biomed Res Int. 2018 May 24;2018:5362810. doi: 10.1155/2018/5362810. eCollection 2018.
  3. The Association of Gut Microbiota with Nonalcoholic Steatohepatitis in Thais.Sobhonslidsuk A, Chanprasertyothin S, Pongrujikorn T, Kaewduang P, Promson K, Petraksa S, Ongphiphadhanakul B.Biomed Res Int. 2018 Jan 16;2018:9340316. doi: 10.1155/2018/9340316. eCollection 2018.
  4. Urinary Metabolomic Profiling in Chronic Hepatitis B Viral Infection Using Gas Chromatography/Mass SpectrometryDittharot K, Jittorntam P, Wilairat P, Sobhonslidsuk A.Asian Pac J Cancer Prev. 2018 Mar 27;19(3):741-748.
  5. Normal Values of High-Resolution Manometry in Supine and Upright Positions in a Thai Population.Hiranyatheb P, Chakkaphak S, Chirnaksorn S, Lekhaka P, Petsrikun K, Somboonpun K.Dig Dis Sci. 2018 Jan;63(1):173-183. doi: 10.1007/s10620-017-4838-x. Epub 2017 Nov 1

 

2017

  1. Reversal of Proximal Renal Tubular Dysfunction after Nucleotide Analogue Withdrawal in Chronic Hepatitis B.Sobhonslidsuk A, Numthavaj P, Wanichanuwat J, Sophonsritsuk A, Petraksa S, Pugasub A, Jittorntam P, Kongsomgan A, Roytrakul S, Phakdeekitcharoen B.Biomed Res Int. 2017;2017:4327385. doi: 10.1155/2017/4327385. Epub 2017 Oct 29.
  2. Normal Values of High-Resolution Manometry in Supine and Upright Positions in a Thai Population.Hiranyatheb P, Chakkaphak S, Chirnaksorn S, Lekhaka P, Petsrikun K, Somboonpun K.Dig Dis Sci. 2018 Jan;63(1):173-183. doi: 10.1007/s10620-017-4838-x. Epub 2017 Nov 15.
  3. The detection of hepatocellular carcinoma (HCC) from patients' breath using canine scent detection: a proof-of-concept study.Kitiyakara T, Redmond S, Unwanatham N, Rattanasiri S, Thakkinstian A, Tangtawee P, Mingphruedhi S, Sobhonslidsuk A, Intaraprasong P, Kositchaiwat C.J Breath Res. 2017 Sep 13;11(4):046002. doi: 10.1088/1752-7163/aa7b8e.
  4. The inverse effect of meal intake on controlled attenuation parameter and liver stiffness as assessed by transient elastography.Ratchatasettakul K, Rattanasiri S, Promson K, Sringam P, Sobhonslidsuk A.BMC Gastroenterol. 2017 Apr 13;17(1):50. doi: 10.1186/s12876-017-0609-6.
  5. An international survey of polypectomy training and assessment.Patel K, Rajendran A, Faiz O, Rutter MD, Rutter C On Behalf Of Bsg Trainees Section, Jover R, Koutroubakis I, Januszewicz W, Ferlitsch M, Dekker E, MacIntosh D, Ng SC, Kitiyakara T, Pohl H, Thomas-Gibson S.Endosc Int Open. 2017 Mar;5(3):E190-E197. doi: 10.1055/s-0042-119949.

 

2016

  1. Nucleotide Analogue-Related Proximal Renal Tubular Dysfunction during Long-Term Treatment of Chronic Hepatitis B: A Cross-Sectional Study.Sobhonslidsuk A, Wanichanuwat J, Numthavaj P, Sophonsritsuk A, Petraksa S, Pugasub A, Jittorntam P, Kongsomgan A, Roytrakul S, Phakdeekitcharoen B.Gastroenterol Res Pract. 2016;2016:2952635. Epub 2016 Oct 3
  2. The incidence, presentation, outcomes, risk of mortality and economic data of drug-induced liver injury from a national database in Thailand: a population-base study.Sobhonslidsuk A, Poovorawan K, Soonthornworasiri N, Pan-Ngum W, Phaosawasdi K.BMC Gastroenterol. 2016 Oct 28;16(1):135.
  3. Advances in Management of Hepatocellular Carcinoma.Intaraprasong P, Siramolpiwat S, Vilaichone RK.Asian Pac J Cancer Prev. 2016;17(8):3697-70 Review.
  4. Health economic evaluation of Gd-EOB-DTPA MRI vs ECCM-MRI and multi-detector computed tomography in patients with suspected hepatocellular carcinoma in Thailand and South Korea.Lee JM, Kim MJ, Phongkitkarun S, Sobhonslidsuk A, Holtorf AP, Rinde H, Bergmann K.J Med Econ. 2016 Aug;19(8):759-68. doi: 10.3111/13696998.2016.1171230. Epub 2016 Apr 27.
  5. Liver Stiffness Measurement in Psoriasis: Do Metabolic or Disease Factors Play the Important Role?Pongpit J, Porntharukchareon S, Kaewduang P, Promson K, Stitchantrakul W, Petraksa S, Thakkinstian A, Kositchaiwat C, Rajatanavin N, Sobhonslidsuk A.Biomed Res Int. 2016;2016:7963972. doi: 10.1155/2016/7963972. Epub 2016 Feb 23.

 

2015

  1. Efficacy of Second Generation Direct-Acting Antiviral Agents for Treatment Naïve Hepatitis C Genotype 1: A Systematic Review and Network Meta-Analysis.Suwanthawornkul T, Anothaisintawee T, Sobhonslidsuk A, Thakkinstian A, Teerawattananon Y.PLoS One. 2015 Dec 31;10(12):e0145953. doi: 10.1371/journal.pone.0145953. eCollection 2015. Review.
  2. Transient Elastography in End-Stage Renal Disease Patients on Hemodialysis: The Effect of Net Fluid Withdrawal.Khunpakdee N, Jayanama K, Kaewdoung P, Promson K, Rattanasiri S, Warodomwichit D, Kantachuvesiri S, Sobhonslidsuk A.Blood Purif. 2015;40(3):256-9. doi: 10.1159/00043958 Epub 2015 Oct 3.
  3. A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury.Luangchosiri C, Thakkinstian A, Chitphuk S, Stitchantrakul W, Petraksa S, Sobhonslidsuk A.BMC Complement Altern Med. 2015 Sep 23;15:334. doi: 10.1186/s12906-015-0861-7.
  4. Current position of vasoconstrictor and albumin infusion for type 1 hepatorenal syndrome.Sobhonslidsuk A. World J Gastrointest Pharmacol Ther. 2015 Aug 6;6(3):28-31. doi: 10.4292/wjgpt.v6.i3.28.
  5. Non-alcoholic fatty liver disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes.Sobhonslidsuk A, Pulsombat A, Kaewdoung P, Petraksa S.Asian Pac J Cancer Prev. 2015;16(5):1789-94.
  6. Health-related quality of life and happiness within an internal medicine residency training program: a longitudinal follow-up study.Sobhonslidsuk A, Thakkinstian A, Satitpornkul P.J Educ Eval Health Prof. 2015 Feb 25;12:3. doi: 10.3352/jeehp.2015.12.3. eCollection 2015.
  7. Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection.Colvin RA, Tanwandee T, Piratvisuth T, Thongsawat S, Hui AJ, Zhang H, Ren H, Chen PJ, Chuang WL, Sobhonslidsuk A, Li R, Qi Y, Praestgaard J, Han Y, Xu J, Stein DS; ABF656A2206 Study Group.J Gastroenterol Hepatol. 2015 Jan;30(1):184-91. doi: 10.1111/jgh.12671.

 

2014

  1. Ultrasound surveillance for hepatocellular carcinoma of at-risk patients in Ramathibodi Hospital.Prapruttam D, Suksai J, Kitiyakara T, Phongkitkarun S.J Med Assoc Thai. 2014 Nov;97(11):1199-208.

 

2013

  1. Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL study.Johnson PJ, Qin S, Park JW, Poon RT, Raoul JL, Philip PA, Hsu CH, Hu TH, Heo J, Xu J, Lu L, Chao Y, Boucher E, Han KH, Paik SW, Robles-Aviña J, Kudo M, Yan L, Sobhonslidsuk A, Komov D, Decaens T, Tak WY, Jeng LB, Liu D, Ezzeddine R, Walters I, Cheng AL.J Clin Oncol. 2013 Oct 1;31(28):3517-24. doi: 10.1200/JCO.2012.48.4410. Epub 2013 Aug 26.
  2. The association between cytokine gene polymorphisms and graft rejection in liver transplantation: a systematic review and meta-analysis.Rattanasiri S, McDaniel DO, McEvoy M, Anothaisintawee T, Sobhonslidsuk A, Attia J, Thakkinstian A. Transpl Immunol. 2013 Jan;28(1):62-70. doi: 10.1016/j.trim.2012.10.003. Epub 2012 Oct 24.

 

2012

  1. The association between cytokine gene polymorphisms and graft rejection in liver transplantation: A systematic review and meta-analysis. Rattanasiri S, McDaniel DO, McEvoy M, Anothaisintawee T, Sobhonslidsuk A, Attia J, Thakkinstian A. Transpl Immunol. 2013 Jan;28(1):62-70.
  2. Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis. Braden B, Halliday J, Aryasingha S, Sharifi Y, Checchin D, Warren BF, Kitiyakara T, Travis SP, Chapman RW. Clin Gastroenterol Hepatol. 2012 Mar;10(3):303-8.

2011 [Abstract]

  1. Analysis of exon 8 of ATP7B gene in Thai patients with Wilson disease. Keandaungjuntr J, Busabaratana M,Kositchaiwat C, Sura T, Pulkes T. J Med Assoc Thai. 2011 Oct;94(10):1184-8.
  2. 'Short' double-balloon enteroscope endoscopic retrograde cholangiopancreatography in patients with a surgically altered upper gastrointestinal tract. Cho S, Kamalaporn P, Kandel G, Kortan P, Marcon N, May G. Can J Gastroenterol. 2011 Nov;25(11):615-9.
  3. Risk for Colorectal Neoplasia in Patients With Colonic Crohn's Disease and Concomitant Primary Sclerosing Cholangitis. Braden B, Halliday J, Aryasingha S, Sharifi Y, Checchin D, Warren BF, Kitiyakara T, Travis SP, Chapman RW.Clin Gastroenterol Hepatol. 2011 Oct 28.
  4. Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients. Patel K, Thompson AJ, Chuang WL, Lee CM, Peng CY, Shanmuganathan G, Thongsawat S, Tanwandee T, Mahachai V, Pramoolsinsap C, Cho M, Han KH, Shah SR, Foster GR, Clark PJ, Pulkstenis E, Subramanian GM, McHutchison JG. J Gastroenterol Hepatol. 2011 Jul;26(7):1182-8.

2010 [Abstract]

  1. Donor outcomes after living donor liver transplantation (LDLT). Intaraprasong P, Sobhonslidsuk A, Tongprasert S. J Med Assoc Thai. 2010 Nov;93(11):1340-3.
  2. The role of liquid simethicone in enhancing endoscopic visibility prior to esophagogastroduodenoscopy (EGD): A prospective, randomized, double-blinded, placebo-controlled trial. Keeratichananont S, Sobhonslidsuk A, Kitiyakara T, Achalanan N, Soonthornpun S. J Med Assoc Thai. 2010 Aug;93(8):892-7.
  3. Asian consensus on irritable bowel syndrome. Gwee KA, Bak YT, Ghoshal UC, Gonlachanvit S, Lee OY, Fock KM, Chua AS, Lu CL, Goh KL, Kositchaiwat C, Makharia G, Park HJ, Chang FY, Fukudo S, Choi MG, Bhatia S, Ke M, Hou X, Hongo M; Asian Neurogastroenterology and Motility Association. J Gastroenterol Hepatol. 2010 Jul;25(7):1189-205. Review.
  4. Evaluation of donors for living donor liver transplantation (LDLT). Sobhonslidsuk A, Intaraprasong P, Tongprasert S. J Med Assoc Thai. 2010 May;93(5):637-41.

2009 Abstract

  1. Improving quality of colonoscopy by adding simethicone to sodium phosphate bowel preparation. Tongprasert S, Sobhonslidsuk A, Rattanasiri S. World J Gastroenterol. 2009 Jun 28;15(24):3032-7.
  2. Thalidomide for the treatment of chronic gastrointestinal bleeding from angiodysplasias: a case series.Kamalaporn P, Saravanan R, Cirocco M, May G, Kortan P, Kandel G, Marcon N. Eur J Gastroenterol Hepatol. 2009 Dec; 21(12):1347-50.

2008

  1. Entecavir therapy for lamivudine-refractory chronic hepatitis B: improved virologic, biochemical, and serology outcomes through 96 weeks. Sherman M, Yurdaydin C, Simsek H, Silva M, Liaw YF, Rustgi VK, Sette H, Tsai N, Tenney DJ, Vaughan J, Kreter B, Hindes R; AI463026 Benefits of Entecavir for Hepatitis B Liver Disease (BEHoLD) Study Group. Hepatology. 2008 Jul;48(1):99-108.
  2. Chemoprevention and screening in primary sclerosing cholangitis. Kitiyakara T, Chapman RW. Postgrad Med J. 2008 May;84(991):228-37.

2007

  1. Comparison of Prevention of NSAID-Induced Gastrointestinal Complications by Rebamipide and Misoprostol: A Randomized, Multicenter, Controlled Trial-STORM STUDY. Park SH, Cho CS, Lee OY, Jun JB, Lin SR, Zhou LY, Yuan YZ, Li ZS, Hou XH, Zhao HC, Kachintorn U, Kositchaiwat C, Lertkupinit C. J Clin Biochem Nutr. 2007 Mar;40(2):148-155.
  2. Fatal fulminant hepatitis associated with Ganoderma lucidum (Lingzhi) mushroom powder. Wanmuang H, Leopairut J, Kositchaiwat C, Wananukul W, Bunyaratvej S. J Med Assoc Thai. 2007 Jan;90(1):179-81.
  3. Combined liver-kidney transplantation in a patient with acute liver failure coexisting with acute renal failure.Sobhonslidsuk A, Phakdeekitcharoen B, Leelaudomlipi S, Pootrakul P, Viengteeravat S, Sornmayura P, Sriphojanart S. J Med Assoc Thai. 2007 Aug;90(8):1654-6.
  4. Visceral fat and insulin resistance as predictors of non-alcoholic steatohepatitis. Sobhonslidsuk A, Jongjirasiri S, Thakkinstian A, Wisedopas N, Bunnag P, Puavilai G. World J Gastroenterol. 2007 Jul 14;13(26):3614-8.
  5. Dysplastic nodules and small primary carcinoma of the liver: a study detecting the early morphological changes during hepatocarcinogenesis. Sornmayura P, Boonsakan P, Sobhonslidsuk A, Sriphojanart S, Euanorasetr C, Bunyaratvej S. J Med Assoc Thai. 2007 Feb;90(2):352-62.
  6. A prophylactic approach for bone marrow transplantation from a hepatitis B surface antigen-positive donor.Sobhonslidsuk A, Ungkanont A. World J Gastroenterol. 2007 Feb 21;13(7):1138-40.

2006

 

  1. Factors influencing health-related quality of life in chronic liver disease. Sobhonslidsuk A, Silpakit C, Kongsakon R, Satitpornkul P, Sripetch C, Khanthavit A. World J Gastroenterol. 2006 Dec 28;12(48):7786-91.
  2. Failure of hepatitis B surface antibody to protect acute fulminating hepatitis in a renal transplant recipient.Sobhonslidsuk A, Sornmayura P, Sumethkul V. J Med Assoc Thai. 2006 Aug;89 Suppl 2:S257-61.

 

2005

  •  
  1. Factors predisposing to peptic ulcer disease in asymptomatic cirrhotic patients. Kamalaporn P, Sobhonslidsuk A, Jatchavala J, Atisook K, Rattanasiri S, Pramoolsinsap C. Aliment Pharmacol Ther. 2005 Jun 15;21(12):1459-65.
  2. Budd-Chiari-like presentation of hepatic adenoma. Sobhonslidsuk A, Jeffers LJ, Acosta RC, Madariaga JR, Bejarano PA, Guerra JJ, Tzakis AG, Schiff ER. J Gastroenterol Hepatol. 2005 Apr;20(4):653-6.
  3. Non-small-bowel lesions detected by capsule endoscopy in patients with obscure GI bleeding. Kitiyakara T, Selby W. Gastrointest Endosc. 2005 Aug;62(2):234-8.
  4. Cost-effectiveness of thiopurine methyltransferase genotype screening in IBD. Kitiyakara T, Hayat J, McIntyre AS.Aliment Pharmacol Ther. 2005 Mar 15;21(6):790-1; author reply 791-2. No abstract available.

2004

  1. Blastocystis hominis infection in irritable bowel syndrome patients. Tungtrongchitr A, Manatsathit S, Kositchaiwat C, Ongrotchanakun J, Munkong N, Chinabutr P, Leelakusolvong S, Chaicumpa W. Southeast Asian J Trop Med Public Health. 2004 Sep;35(3):705-10.
  2. Adenomatous colonic polyps are rare in ulcerative colitis. Kitiyakara T, Bailey DM, McIntyre AS, Gorard DA. Aliment Pharmacol Ther. 2004 Apr 15;19(8):879-87.
  3. Chronic liver disease questionnaire: translation and validation in Thais. Sobhonslidsuk A, Silpakit C, Kongsakon R, Satitpornkul P, Sripetch C. World J Gastroenterol. 2004 Jul 1;10(13):1954-7.
  4. Competing risks analysis of predictors of delisting owing to tumor progression in liver transplant candidates with hepatocellular carcinoma. Yamashiki N, Gaynor JJ, Kato T, Reddy KR, Sobhonslidsuk A, Levi D, Nishida S, Madariaga J, Nery J, Schiff ER, Tzakis AG. Am J Transplant. 2004 May;4(5):774-81.

2003

  1. Low and high doses of rabeprazole vs. omeprazole for cure of Helicobacter pylori infection. Kositchaiwat C, Ovartlarnporn B, Kachintorn U, Atisook K. Aliment Pharmacol Ther. 2003 Nov 15;18(10):1017-21.
  2. Relation between seroreactivity to low-molecular-weight Helicobacter pylori-specific antigens and disease presentation. Vilaichone RK, Mahachai V, Kositchaiwat C, Graham DY, Yamaoka Y. Clin Diagn Lab Immunol. 2003 Nov;10(6):1025-8.
  3. Twelve-year changes in vascular risk factors and their associations with mortality in a cohort of 3499 Thais: the Electricity Generating Authority of Thailand Study. Sritara P, Cheepudomwit S, Chapman N, Woodward M, Kositchaiwat C, Tunlayadechanont S, Sura T, Hengprasith B, Tanphaichitr V, Lochaya S, Neal B, Tanomsup S, Yipintsoi T; Electricity Generating Authority of Thailand. Int J Epidemiol. 2003 Jun;32(3):461-8.

2002

  1. Guideline for the management of acute diarrhea in adults. Manatsathit S, Dupont HL, Farthing M, Kositchaiwat C, Leelakusolvong S, Ramakrishna BS, Sabra A, Speelman P, Surangsrirat S; Working Party of the Program Committ of the Bangkok World Congress of Gastroenterology 2002. J Gastroenterol Hepatol. 2002 Feb;17 Suppl:S54-71. No abstract available.
  2. Prediction of survival outcome of ICU patients awaiting orthotopic liver transplantation. Sobhonslidsuk A, Neff GW, Molina EG, Yamashiki N, Nishida S, Reddy KR, Tzakis AG, Schiff ER. Transplant Proc. 2002 Jun;34(4):1223-5. No abstract available.
  3. Portal vein thrombosis: a concise review. Sobhonslidsuk A, Reddy KR. Am J Gastroenterol. 2002 Mar;97(3):535-41. Review.
  4. Refractory coeliac disease, small-bowel lymphoma and chorea. Kitiyakara T, Jackson M, Gorard DA. J R Soc Med. 2002 Mar;95(3):133-4. No abstract available.

2001

  1. Experiences with recombinant factor VIIa for the prevention of bleeding in patients with chronic liver disease undergoing percutaneous liver biopsies and endoscopic retrograde cholangiopancreatography (ERCP).Kositchaiwat C, Chuansumrit A. Thromb Haemost. 2001 Oct;86(4):1125-6. No abstract available.
  2. Impact of liver cirrhosis on nutritional and immunological status. Sobhonslidsuk A, Roongpisuthipong C, Nantiruj K, Kulapongse S, Songchitsomboon S, Sumalnop K, Bussagorn N. J Med Assoc Thai. 2001 Jul;84(7):982-8.
  3. Nutritional assessment in various stages of liver cirrhosis. Roongpisuthipong C, Sobhonslidsuk A, Nantiruj K, Songchitsomboon S. Nutrition. 2001 Sep;17(9):761-5
  4. Discrepancy between phenotype and genotype on screening for factor V Leiden after transplantation. Parker J, Pagliuca A, Kitiyakara T, Whitehead M, Heaton N, O'Grady J, Arya R. Blood. 2001 Apr 15;97(8):2525-6. No abstract available.

2000

  1. Acute hepatitis A and acquired immunity to hepatitis A virus in hepatitis B virus (HBV) carriers and in HBV- or hepatitis C virus-related chronic liver diseases in Thailand. Pramoolsinsap C. J Viral Hepat. 2000 May;7 Suppl 1:11-2. Review.
  2. Diagnostic value of endoscopic transampullary biopsy for malignant bile duct stricture. Kositchaiwat S, Kositchaiwat C, Kanchanapitak A, Lerkpatanakit P, Tinnakornrasamee C. J Med Assoc Thai. 2000 Sep;83(9):992-8.

 

  
ภาควิชาอายุรศาสตร์  IntMed.mahidol.ac.th
อาคาร 1 ชั้น 7 คณะแพทยศาสตร์โรงพยาบาลรามาธิบดี มหาวิทยาลัยมหิดล
270 ถนนพระรามที่ 6 แขวงทุ่งพญาไท เขตราชเทวี กรุงเทพมหานคร 10400
โทรศัพท์ 02-201-1301 , 02-201-1391 โทรสาร 02-201-1715